Likvor receives an order for CELDA™ from Uppsala University Hospital
Likvor receives an order for CELDA™ from Uppsala University
Hospital
LinkMed's portfolio company Likvor has received an order
for Likvor CELDA™ from Uppsala University Hospital
(Akademiska Universitetssjukhuset). With
Likvor CELDA™ the
clinic will be able to dynamic measure the most important
parameters concerning the patients' cerebrospinal fluid including
pressure and flow. Likvor CELDA™ was
developed to facility greater understanding and enhancing diagnosis
of normal pressure hydrocephalus (NPH), a condition that is often
mistaken for dementia. This is the second order for the instrument;
the fist came from Norrlands Universitetssjukhus,
Umeå.
Likvor CELDA™ is the first commercially approved instrument for
assessing the flow of CSF fluid that surrounds the brain and spinal
cord. It increases the possibility for patients who suffer from NPH
to receive a correct diagnosis and therefore the appropriate
treatment in the form of a shunt implant that diverts and regulates
CSF pressure and flow. An accurate diagnosis means large gains for
the patient and family, but also for society as a whole.
Likvor CELDA™ is used with a special developed catheter, CELDA
Tools™ that is a disposable for one time use only.
Hidden disease of old age
Normal Pressure Hydrocephalus (NPH) is a relatively unknown
disease that is often mistakenly diagnosed as dementia, Alzheimer's
or Parkinson's. The is because the symptoms, including disturbances
in gait, confusion and urinary incontinence, are similar to those
of dementia, plus that NPH is a condition that mainly occurs in
people over the age of 55. Studies have shown that up to 10 percent
of dementia patients may actually be suffering from NPH. In Sweden
it is estimated that over 7,000 Swedes suffer from the disease -
most of them unnecessarily. In the U.S., the corresponding figure
is well over 375,000. NPH is a condition that is relatively easily
treated by the insertion of a shunt, which helps the patient to
regulate CSF flow and pressure.
Likvor's principal owners are Uminova Invest and LinkMed. For
more information about Likvor visit www.likvor.com.
For more information please contact:
Kjell Öberg, CEO Likvor: +46 70 640 14 92
Okee Williams, Portfolio Manager LinkMed: +46 70 600 5364
Agneta Edberg, Head of Sales and Marketing Likvor +46 70 555
7518
Press release: December 11, 2009